For safety, align with your prescriber on timing, monitoring, and whether to taper or transition to alternatives
GLP-1 wont cause drinking to gently slope downward, rather, it'll spark waves of volatility, with sharp drops in consumption followed by quick rebounds
P =088, I 2 = 0%), see Table 2 (Details were seen in Figure S8-14 )
April 16, 2025 Popular weight loss drugs like Ozempic and Wegovy may cut the risk of Alzheimers disease and other forms of dementia, a large new analysis found
NICE has not yet issued guidance on either agent, as appraisal processes are typically initiated only after regulatory approval, although scoping can occur earlier
What is the scope of misuse of diabetes-approved GLP-1 RAs for weight loss in patients without diabetes